Wan-Jen Hong Selected Research

Bortezomib (Velcade)

8/2022	Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma.
12/2020	Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wan-Jen Hong Research Topics

Disease

11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 01/2014
4	Multiple Myeloma 08/2022 - 12/2020
3	Leukemia 06/2021 - 12/2015
3	Neoplasms (Cancer) 12/2015 - 04/2004
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2022
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2021 - 01/2021
2	Pneumonia (Pneumonitis) 05/2021 - 12/2020
2	Thrombocytopenia (Thrombopenia) 12/2020 - 01/2020
2	Infections 12/2020 - 01/2020
2	Neutropenia 12/2020 - 01/2020
1	Thrombotic Microangiopathies 08/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021
1	Disease Progression 05/2021
1	Septic Shock (Toxic Shock Syndrome) 12/2020
1	Nausea 01/2020
1	Febrile Neutropenia 01/2020
1	B-Cell Leukemia (Leukemia, B Cell) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Hematologic Diseases (Blood Diseases) 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 02/2015
1	Thrombocytosis (Thrombocythemia) 06/2014
1	primary familial and congenital Polycythemia 06/2014
1	Genetic Translocation (Chromosomal Translocation) 01/2014
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2011

Drug/Important Bio-Agent (IBA)

11	venetoclaxIBA 01/2024 - 02/2015
6	Azacitidine (5 Azacytidine)FDA Link 06/2021 - 01/2019
3	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021 - 12/2020
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2015
2	carfilzomibIBA 08/2022 - 10/2021
2	Bortezomib (Velcade)FDA Link 08/2022 - 12/2020
2	atezolizumabIBA 01/2022 - 01/2022
2	Decitabine FDA Link 01/2021 - 01/2019
1	cobimetinibIBA 01/2024
1	RG7388IBA 01/2023
1	ixazomibIBA 08/2022
1	Proteasome InhibitorsIBA 08/2022
1	eculizumab FDA Link 08/2022
1	obinutuzumabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	tazemetostatIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 11/2021
1	vendexIBA 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	CohesinsIBA 12/2015
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2015
1	Thrombopoietin (c-mpl Ligand)IBA 06/2014
1	4,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA 06/2014
1	Oxygen (Dioxygen)IBA 06/2014
1	Erythropoietin FDA Link 06/2014
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 06/2014
1	GelsolinIBA 06/2014
1	EnzymesIBA 06/2014
1	Thrombopoietin ReceptorsIBA 06/2014
1	Centrosomal Associated ProteinsIBA 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Complement Receptors (Complement Receptor)IBA 04/2011

Therapy/Procedure

3	Therapeutics 01/2024 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2024 - 01/2019
1	Induction Chemotherapy 05/2021
1	Aftercare (After-Treatment) 01/2020
1	Transplantation 01/2016
1	Heterologous Transplantation (Xenotransplantation) 01/2016
1	Radiotherapy 04/2004